The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma

Archives of Ophthalmology

Volumn 120, Issue 6, 2002, Pages 701-713

  Kass, Michael A ^a   Heuer, Dale K ^b   Higginbotham, Eve J ^c,d   Johnson, Chris A ^e   Keltner, John L ^f   Philip Miller, J ^a   Parrish II, Richard K ^g   Roy Wilson, M ^h   Gordon, Mae O ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c Maryland Ctr for Eye Care Assoc   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

^e DEVERS EYE INSTITUTE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^h CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; TIMOLOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIGH RISK PATIENT; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; OPTIC DISK ANOMALY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; VISUAL FIELD DEFECT;

EID: 0036269833     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.120.6.701     Document Type: Article

References (43)

1. Number of people with glaucoma worldwide
2. Racial differences in the cause-specific prevalence of blindness in East Baltimore
3. Models of open-angle glaucoma prevalence and incidence in the United States
4. Prevalence and causes of visual impairment in the Barbados Eye Study
5. The prevalence of primary open-angle glaucoma in a population-based study in the Netherlands: The Rotterdam Study
6. Prevalence of open-angle glaucoma
7. Prevalence of open-angle glaucoma in Australia: The Blue Mountains Eye Study
8. National survey of the prevalence and risk factors of glaucoma in St Lucia, West Indies, I: Prevalence findings
9. Glaucoma and intraocular pressure in Jamaica
10. Racial variations in the prevalence of primary open-angle glaucoma: The Baltimore Eye Survey
11. Incidence of open-angle glaucoma: The Barbados Eye Studies
12. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975
13. Biostatistical analysis of the collaborative glaucoma study, I: Summary report of the risk factors for glaucomatous visual-field defects
14. Risk factors for the development of glaucomatous visual field loss in ocular hypertension
15. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons
16. Cost effectiveness of screening for primary open angle glaucoma
17. The definition of pre-glaucoma: A prospective study
18. Routine tonometry in ophthalmic practice, II: Five-year follow-up
19. Uniocular miotic therapy
20. Ocular hypertension: A long-term follow-up of treated and untreated patients
21. Prognostic indicators in ocular hypertension
22. A comparison of treated and untreated glaucoma suspects
23. Topical epinephrine in glaucoma suspects
24. Long-term epinephrine therapy of ocular hypertension
25. Prophylactic therapy of ocular hypertension: A prospective study
26. A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects
27. Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals: A randomized, double-masked, long-term clinical trial
28. Long-term effects of timolol therapy in ocular hypertension:a double-masked, randomized trial
29. Randomized clinical trials on medical treatment of glaucoma: Are they appropriate to guide clinical practice?
30. The Ocular Hypertension Treatment Study: Design and baseline description of the participants
31. Baseline visual field characteristics in the ocular hypertension treatment study
32. The Ocular Hypertension Treatment Study: Reproducibility of cup/disk ratio measurements over time at an optic disc reading center
33. The Glaucoma Symptom Scale: A brief index of glaucoma-specific symptoms
34. Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study
35. Changing frequency of interim analysis in sequential monitoring
36. Computations for group sequential boundaries using the Lan-DeMets spending function method
37. The Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucoma
38. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures
39. The Advanced Glaucoma Intervention Study (AGIS), 7: The relationship between control of intraocular pressure and visual field deterioration